Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify® in the U.S.Business Wire • 07/29/22
Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. MarketBusiness Wire • 07/27/22
Dr. Reddy's Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. MarketBusiness Wire • 07/22/22
Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. MarketBusiness Wire • 07/08/22
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRxBusiness Wire • 07/05/22
Dr. Reddy's Laboratories Announces the Acquisition of an Injectable Product Portfolio from Eton PharmaBusiness Wire • 06/24/22
Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. marketBusiness Wire • 06/14/22
Dr. Reddy's Laboratories Announces the Launch of Pemetrexed for Injection USP, in the U.S. MarketBusiness Wire • 05/27/22
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q4 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/19/22
Dr. Reddy's Laboratories Announces the Launch of Posaconazole Delayed-Release Tablets in the U.S. MarketBusiness Wire • 04/20/22
Dr. Reddy's Laboratories Announces the Launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. MarketBusiness Wire • 04/05/22
Dr. Reddy's Laboratories and MediCane Health Announce the Launch of Medical Cannabis Products in GermanyBusiness Wire • 04/01/22
Dr. Reddy's Laboratories Announces the Launch of Its Authorized Generic Version of VASOSTRICT® (vasopressin injection, USP) Vials in the U.S. MarketBusiness Wire • 02/09/22
NYSE-Listed Pharma Co. Dr. Reddy's To Acquire German Medical Cannabis Firm Nimbus Health GmbHBenzinga • 02/04/22
Dr. Reddy's Laboratories Enters Into Definitive Agreement to Acquire German Medical Cannabis Firm Nimbus Health GmbHBusiness Wire • 02/03/22
Dr. Reddy's Included in S&P Global's Sustainability Yearbook for the 2nd Year and Bloomberg Gender-Equality Index for the 5th Year in a RowBusiness Wire • 02/02/22
Dr. Reddy's Laboratories Limited (RDY) CEO Erez Israeli on Q3 2022 Results - Earnings Call TranscriptSeeking Alpha • 01/28/22
Dr. Reddy's and Prestige BioPharma announce partnership to commercialize biosimilar for cancer treatment in select countries in Latin America and Southeast AsiaBusiness Wire • 12/15/21